SCHEMBL4151708

SCHEMBL4151708

COc1ccc(Cl)cc1C1=C(B(O)O)CCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.42
ALDH1A1 P00352 7/20 0.41
HPGD P15428 5/20 0.41
KDM4E B2RXH2 3/20 0.39
USP2 O75604 1/20 0.37
PRNP P04156 1/20 0.37
PPARG P37231 1/20 0.37
MAPK10 P53779 1/20 0.37
NCOA2 Q15596 1/20 0.37
NCOA1 Q15788 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HSD17B10 Q99714 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
LMNA P02545 1/20 0.37
RECQL P46063 1/20 0.36
SLC9A1 P19634 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4924977 0.97 ALDH1A1 (0.44) ERN1ALDH1A1HPGDKDM4EUSP2
SCHEMBL4158464 0.81 SMN1; SMN2 (0.43) ERN1ALDH1A1HPGDKDM4EUSP2
SCHEMBL4159004 0.80 PTGER1 (0.39) NPSR1MAPTCYP2C9PTGER1RAB9A
SCHEMBL5620731 0.78 PTGER1 (0.61) CYP2C9PTGER1
SCHEMBL5619573 0.76 PTGER1 (0.56) CYP2C9PTGER1
SCHEMBL4925866 0.76 PTGER1 (0.58) CYP2C9PTGER1
SCHEMBL7699644 0.72 ALDH1A1 (0.56) ERN1ALDH1A1HPGDKDM4EUSP2
SCHEMBL17254341 0.71 ERN1 (0.48) ERN1ALDH1A1HPGDKDM4EUSP2
SCHEMBL322537 0.69 ENPP2 (0.52) ERN1ALDH1A1HPGDKDM4ELMNA
SCHEMBL4914496 0.67 ALDH1A1 (0.40) ERN1ALDH1A1HPGDKDM4EUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090227591-A1 Cyclopentene compounds GLAXO GROUP LIMITED (GB) 2009-09-10 US disclosed
US-20090227591-A1 Cyclopentene compounds GLAXO GROUP LIMITED (GB) 2009-09-10 US disclosed
US-20090227591-A1 Cyclopentene compounds GLAXO GROUP LIMITED (GB) 2009-09-10 US disclosed
EP-1670763-A1 CYCLOPENTENE COMPOUNDS GLAXO GROUP LIMITED (GB) 2006-06-21 EP disclosed
WO-2005037793-A1 CYCLOPENTENE COMPOUNDS GLAXO GROUP LIMITED (GB) 2005-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227591-A1 Cyclopentene compounds C1R, CYP1B1, ADORA2B ERN1 1619/4885ALDH1A1 1534/4885HPGD 2409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.